Table S1 from Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription
Year: 2023
Type: other
Abstract: Supplementary Table 1 shows the enitociclib toxicity in a panel of lymphoma cell lines ranked by IC50
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4388525838
